Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
Lennox International Inc. · LII · FY2026 Q2 · Calendar Q3 2026
Lennox's commercial growth, acquisition expansion, and product investment support the longer-term growth case, but Q2 evidence is mixed: residential weakness lowered EPS guidance and creates a near-term test for margin recovery.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
The key change was a lower full-year adjusted EPS outlook, alongside a reduction in expected Home Comfort Solutions growth. Commercial momentum remained strong, residential volume weakened, and Lennox completed the Comfort-Aire and Century acquisition.
Full-year adjusted EPS guidance was lowered to $23-$24; HCS growth is now expected at about 1% versus 4% previously, while overall revenue growth remains about 8%.
Follow LII with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 free1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Deutsche Bank | Hold | Buy | Downgrade | Sep 14, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Sep 3, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 30, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Mar 5, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jan 16, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Nov 13, 2025 |
| UBS | Neutral | Neutral | Maintain | Oct 27, 2025 |
| Mizuho | Neutral | Neutral | Maintain | Oct 17, 2025 |
| Baird | Neutral | Neutral | Maintain | Jul 17, 2025 |
| Stephens & Co. | Overweight | Overweight | Maintain | Mar 7, 2025 |
| Keybanc | Overweight | Downgrade | Oct 15, 2024 | |
| TD Cowen | Buy | Buy | Maintain | Jun 21, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | Jul 13, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Oct 28, 2022 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Jul 8, 2022 |
| Vertical Research | Sell | Hold | Downgrade | Jun 1, 2021 |
| Seaport Global | Neutral | Buy | Downgrade | Jul 21, 2020 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 8, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 8, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 24, 2018 |
| Stifel | Hold | Hold | Maintain | Apr 24, 2018 |
| Susquehanna | Neutral | Positive | Downgrade | Aug 15, 2016 |
| Longbow Research | Neutral | Buy | Downgrade | Nov 19, 2015 |
| Nomura | Neutral | Buy | Downgrade | Apr 21, 2015 |
| MKM Partners | Buy | Neutral | Upgrade | Apr 22, 2014 |
| Global Hunter Securities | Buy | Accumulate | Maintain | Jul 23, 2013 |
Upside is calculated against the persisted current price $372.34. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Deutsche Bank | Analyst unavailable | $444 | $366.04 | +19.2% | Sep 14, 2026 |
| Morgan Stanley | Christopher Snyder | $375 | $376.35 | +0.7% | Sep 3, 2026 |
| Goldman Sachs | Joe Ritchie | $547 | $417.45 | +46.9% | Jul 31, 2026 |
| RBC Capital | Deane Dray | $469 | $417.4 | +26.0% | Jul 30, 2026 |
| Oppenheimer | Noah Kaye | $650 | $544.11 | +74.6% | Apr 30, 2026 |
| Robert W. Baird | Analyst unavailable | $550 | $517.62 | +47.7% | Apr 30, 2026 |
| Vertical Research | Analyst unavailable | $600 | $517.62 | +61.1% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $597 | $517.62 | +60.3% | Apr 30, 2026 |
| BNP Paribas | Analyst unavailable | $535 | $517.88 | +43.7% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $450 | $495.08 | +20.9% | Feb 1, 2026 |
| Goldman Sachs | Analyst unavailable | $592 | $495.08 | +59.0% | Jan 31, 2026 |
| RBC Capital | Deane Dray | $534 | $490.76 | +43.4% | Jan 29, 2026 |
| Oppenheimer | Analyst unavailable | $630 | $482.84 | +69.2% | Jan 29, 2026 |
| Robert W. Baird | Analyst unavailable | $572 | $487.49 | +53.6% | Jan 29, 2026 |
| Mizuho Securities | Analyst unavailable | $525 | $487.49 | +41.0% | Jan 29, 2026 |
| RBC Capital | Deane Dray | $563 | $520.04 | +51.2% | Jan 15, 2026 |
| Barclays | Julian Mitchell | $667 | $519.85 | +79.1% | Jan 7, 2026 |
| UBS | Analyst unavailable | $530 | $503.89 | +42.3% | Jan 5, 2026 |
| Barclays | Julian Mitchell | $680 | $505.78 | +82.6% | Dec 11, 2025 |
| Wells Fargo | Joseph O'Dea | $525 | $500.01 | +41.0% | Dec 4, 2025 |
| UBS | Damian Karas | $560 | $506.75 | +50.4% | Oct 27, 2025 |
| Northcoast Research | Aaron Reed | $525 | $501.17 | +41.0% | Oct 27, 2025 |
| RBC Capital | Analyst unavailable | $555 | $498.17 | +49.1% | Oct 23, 2025 |
| Wells Fargo | Joseph O'Dea | $545 | $493.07 | +46.4% | Oct 23, 2025 |
| Morgan Stanley | Christopher Snyder | $475 | $497.73 | +27.6% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $700 | $493.07 | +88.0% | Oct 23, 2025 |
| Mizuho Securities | Analyst unavailable | $565 | $523.94 | +51.7% | Oct 17, 2025 |
| Wells Fargo | Joseph O'Dea | $575 | $550.63 | +54.4% | Oct 6, 2025 |
| UBS | Damian Karas | $676 | $653.51 | +81.6% | Jul 28, 2025 |
| Oppenheimer | Noah Kaye | $600 | $509.14 | +61.1% | Apr 24, 2025 |
| Wells Fargo | Joseph O'Dea | $580 | $582.93 | +55.8% | Feb 3, 2025 |
| Mizuho Securities | Brett Linzey | $675 | $609.74 | +81.3% | Oct 24, 2024 |
| RBC Capital | Deane Dray | $619 | $609.74 | +66.2% | Oct 24, 2024 |
| Barclays | Julian Mitchell | $624 | $609.74 | +67.6% | Oct 24, 2024 |
| KeyBanc | Jeffrey Hammond | $600 | $606.64 | +61.1% | Oct 15, 2024 |
| Robert W. Baird | Timothy Wojs | $648 | $604.04 | +74.0% | Oct 14, 2024 |
| Robert W. Baird | Timothy Wojs | $610 | $557.19 | +63.8% | Jul 15, 2024 |
| Wells Fargo | Joseph O'Dea | $570 | $535.61 | +53.1% | Jul 9, 2024 |
| Wells Fargo | Joseph O'Dea | $520 | $467.85 | +39.7% | Apr 25, 2024 |
| RBC Capital | Deane Dray | $510 | $467.85 | +37.0% | Apr 25, 2024 |
| KeyBanc | Jeffrey Hammond | $515 | $467.93 | +38.3% | Apr 10, 2024 |
| RBC Capital | Deane Dray | $481 | $465.99 | +29.2% | Apr 4, 2024 |
| Mizuho Securities | Brett Linzey | $460 | $377.3 | +23.5% | Oct 16, 2023 |
| RBC Capital | Deane Dray | $391 | $357.42 | +5.0% | Aug 17, 2023 |
| Wells Fargo | Analyst unavailable | $300 | $260.76 | -19.4% | Feb 1, 2023 |
| Morgan Stanley | Analyst unavailable | $258 | $241.69 | -30.7% | Jan 6, 2023 |
| Wells Fargo | Analyst unavailable | $294 | $235.91 | -21.0% | Jan 5, 2023 |
| UBS | Damian Karas | $265 | $246.48 | -28.8% | Dec 15, 2022 |
| Morgan Stanley | Analyst unavailable | $279 | $248.64 | -25.1% | Dec 15, 2022 |
| Barclays | Analyst unavailable | $228 | $220.52 | -38.8% | Oct 3, 2022 |
| Morgan Stanley | Analyst unavailable | $268 | $243.88 | -28.0% | Sep 1, 2022 |
| Morgan Stanley | Analyst unavailable | $255 | $243.99 | -31.5% | Aug 1, 2022 |
| Wells Fargo | Analyst unavailable | $249 | $239.53 | -33.1% | Aug 1, 2022 |
| Mizuho Securities | Analyst unavailable | $210 | $213.59 | -43.6% | Jul 18, 2022 |
| Morgan Stanley | Analyst unavailable | $222 | $217.46 | -40.4% | Jul 15, 2022 |
| Deutsche Bank | Analyst unavailable | $292 | $216.92 | -21.6% | Jul 13, 2022 |
| Barclays | Analyst unavailable | $230 | $219.62 | -38.2% | Jul 8, 2022 |
| Wells Fargo | Analyst unavailable | $231 | $202.46 | -38.0% | Jun 29, 2022 |
| Goldman Sachs | Analyst unavailable | $190 | $188.29 | -49.0% | Jun 23, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $238 | $211.56 | -36.1% | Jun 7, 2022 |
| Barclays | Analyst unavailable | $240 | $202.49 | -35.5% | May 24, 2022 |
| Mizuho Securities | Analyst unavailable | $225 | $227.32 | -39.6% | Apr 26, 2022 |
| Stephens | Analyst unavailable | $275 | $227.72 | -26.1% | Apr 26, 2022 |
| Barclays | Analyst unavailable | $260 | $235.11 | -30.2% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $242 | $238.94 | -35.0% | Apr 26, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $254 | $226.75 | -31.8% | Apr 26, 2022 |
| Barclays | Julian Mitchell | $300 | $262.16 | -19.4% | Apr 5, 2022 |
| Deutsche Bank | Nicole DeBlase | $393 | $324.93 | +5.5% | Dec 16, 2021 |
| Goldman Sachs | Joe Ritchie | $310 | $300.86 | -16.7% | Oct 26, 2021 |
| Wolfe Research | Nigel Coe | $302 | $339.45 | -18.9% | Jul 12, 2021 |
| Vertical Research | Jeffrey Sprague | $300 | $344.9 | -19.4% | Jun 1, 2021 |
Track every rating change on LII the moment it posts. Free to start.
Start freeLennox International Inc. is a global manufacturer and distributor specializing in heating, ventilation, air conditioning (HVAC), and refrigeration solutions. The company operates across three divisions: Residential Heating & Cooling, Commercial Heating & Cooling, and Refrigeration. Its Residential Heating & Cooling division supplies homeowners with systems like furnaces, air conditioners, and heat pumps, along with indoor air quality products, comfort controls, and replacement components, catering to both new construction and existing residential upgrades.…
| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
| DCI Donaldson Company, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1.8% | +2.1% | Donaldson posts record FY26 and targets further growth |
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.